BIOCOM for BIOCOM
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report (this page) | Aug 6, 2012 | $52,000 | Replaced |
| 2nd Quarter - Report | Aug 6, 2012 | $52,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
- Voiced support for Medical Device Excise Tax Repeal Efforts, HR 463 - Voiced Support for HR4953, the Qualifying Renewable Chemical Production Tax Credit Act of 2012
| Lobbyist | Covered position, as disclosed |
|---|---|
| MADELEINE BAUDOIN | — |
| JOE PANETTA | — |
Health Issues HCR
Voiced Support for the FDA User Fee Reauthorization. Voiced Support for the "Breakthroughs" provision included in the FDA User Fee Reauthorization. Voiced Support for the de novo process changes in FDA User Fee Reauthorization. Voiced Support for GAIN within the FDA User Fee package
| Lobbyist | Covered position, as disclosed |
|---|---|
| MADELEINE BAUDOIN | — |
| JOE PANETTA | — |
Energy/Nuclear ENG
Voiced Support for the Energy Title programs within the 2002 and 2008 farm bills to be included in the new Farm Bill.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MADELEINE BAUDOIN | — |
| JOE PANETTA | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.